NCT00004148View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

April 30, 2006

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

recombinant vaccinia-B7.1 vaccine

Trial Locations (1)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004148 - Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma | Biotech Hunter | Biotech Hunter